What is it about?
Observed in real life of over 19,000 individuals with type 1 diabetes, transitions from predictive low glucose suspend system to automated insulin delivery resulted in improvement of all glycemic parameters, equivalent to improvements observed in randomized clinical trials, and reduced user-initiated boluses. However, glycemic and behavioral changes with AID use may differ greatly across different demographic and clinical groups.
Featured Image
Read the Original
This page is a summary of: Biobehavioral Changes Following Transition to Automated Insulin Delivery: A Large Real-life Database Analysis, Diabetes Care, September 2022, American Diabetes Association,
DOI: 10.2337/dc22-1217.
You can read the full text:
Contributors
Be the first to contribute to this page







